Keynote Lecture
US and ESC heart failure guidelines – Contrast and similarities
C. Yancy, USA
Plenary session
PCSK-9 inhibitors in high risk patients
G. Steg, France
Sponsored by Sanofi
Luncheon Symposium I
Sponsored by Boehringer Ingelheim
The changing treatment paradigms in diabetes: A role for cardiologists
A. Grossman, Israel
Luncheon Symposium II
Sponsored by AstraZeneca
DAPT in HRPMI patients: From beginning to end
M. Bonaca, USA
Is aspirin enough in DM patients?
G. Steg, France
Panel Discussion
Moderator: D. Hasdai, Israel
Panel members: M. Bonaca, USA; G. Steg, France; D. Zahger, Israel
Luncheon Symposium III
Sponsored by Novo Nordisk
New perspectives on managing CV risk in T2D
R. Beigel, Israel
Renal outcomes in T2D – the role of Glp-1RA
A. Cahn, Israel
